BHARATHAN, Indu T.,BLACKBURN, Chris,CIAVARRI, Jeffrey P.,CHOUITAR, Jouhara,CULLIS, Courtney A.,DAMORE, Natalie,FLEMING, Paul E.,GIGSTAD, Kenneth M.,GIPSON, Krista E.,GIRARD, Mario,HU, Yongbo,LEE, Jani
申请号：
EP15737173
公开号：
EP3094325A4
申请日:
2015.01.13
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
and pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, R4, R5, L1, L2, m, and n, are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
